Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Genomics|October 19, 2018
The underlying pathway involved in inter-subspecific hybrid male sterility in riceJianwei Shan, Zhongquan Cai, Yu Zhang, et al.Cell Reports|July 1, 2023
Phosphorylation by ATR triggers FANCD2 chromatin loading and activates the Fanconi anemia pathwayMarian Kupculak, Fengxiang Bai, Qiang Luo, et al.Cell Reports|November 13, 2024
PP2A licenses the FANCD2/FANCI complex for chromosome loadingDi Yang, Fengxiang Bai, David Lopez Martinez, et al.Eye (London, England)|October 29, 2023
Association of macular outward scleral height with axial length, macular choroidal thickness and morphologic characteristics of the optic disc in Chinese adultsMenghan Li, Hannan Xu, Luyao Ye, et al.Ophthalmology and Therapy|September 29, 2022
Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression StudyLuyao Ye, Hannan Xu, Ya Shi, et al.Acta Ophthalmologica|December 8, 2025
Four-year longitudinal choroidal thickness changes and tessellated fundus progression in an eastern Chinese populationMenghan Li, Yanping Chen, Luyao Ye, et al.Nature Communications|December 30, 2025
A multi-grained symmetric differential equation model for learning protein-ligand binding dynamicsShengchao Liu, Weitao Du, Hannan Xu, et al.Investigative Ophthalmology & Visual Science|April 12, 2023
Potential Choroidal Mechanisms Underlying Atropine's Antimyopic and Rebound Effects: A Mediation Analysis in a Randomized Clinical TrialHannan Xu, Luyao Ye, Yajun Peng, et al.JAMA Ophthalmology|July 24, 2025
Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical TrialHannan Xu, Moxin Chen, Luyao Ye, et al.Pageof 1